Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital

Stroke, Acute Clinical Trial

— RARETBAS  

Official title:

Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04177615
• Other study ID #: yds2019
• Status: Not yet recruiting
• Phase: N/A
• Start date: November 19, 2019
• Est. completion date: December 30, 2020

Study information

• Verified date: November 2019
• Source: Ho Chi Minh City University of Medicine and Pharmacy
• Contact: DUNG U Tran Nguyen
• Phone: 0902610832
• Email: uyendungtrannguyen[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a prospective, open lable studies conducted in 115 hospital to compare between thromboectomy and Recombinant Tisue Plasminogen Activator only to evaluate the eficacy and safety of endovascular treatment in basilar artery occlusion stroke patients

Description:

Acute basilar artery thrombosis is associated with a poor prognosis. Prevalence of basilar artery occlusion are not known. Although basilar artery occlusion has been reported in 2 per 1000 autopsy cases, basilar artery thrombosis may, in stroke registries, explain as many as 27% of ischemic strokes occurring in the posterior circulation.Various treatments were tried in groups of patients with vertebrobasilar territory infarction but evidence based was not cleared previous studies. Therefore, we conduct this study to evaluate the eficacy and safety of endovascular treatment in basilar artery occlusion stroke patients

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 109
• Est. completion date: December 30, 2020
• Est. primary completion date: November 19, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients admit to 115 hospital in 24h of Basilar Artery Occlusion Stroke

• NIHSS > 4 points

Exclusion Criteria:

• Patients refuse to participate in studies

• Patients with contraindication of either rTPA or thromboectomy

Related Conditions & MeSH terms

• Arterial Occlusive Diseases
• Basilar Artery Occlusion
• Stroke
• Stroke, Acute

Intervention

Procedure:
• Thromboectomy
Thromboectomy in Basilar Artery Occlusion patients

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Ho Chi Minh City University of Medicine and Pharmacy

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	NIHSS in patients wtih Basilar Artery Occlusion Stroke after 24hour admission	NIHSS in patients wtih Basilar Artery Occlusion Stroke after 24hour admission	24 hours from admission
Primary	Survival rate in patients with Basilar Artery Occlusion Stroke	Survival rate in patients with Basilar Artery Occlusion Stroke	3 months from admission
Secondary	mRS in patients with Basilar Artery Occlusion Stroke	mRS in patients with Basilar Artery Occlusion Stroke	3 months from admission